Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo

AIDS Research and Human Retroviruses

Volumn 24, Issue 3, 2008, Pages 453-462

  Biancotto, Angélique ^a   Iglehart, Sarah J ^a   Lisco, Andrea ^a   Vanpouille, Christophe ^a   Grivel, Jean Charles ^a   Lurain, Nell S ^b   Reichelderfer, Patricia S ^a   Margolis, Leonid B ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4; GREEN FLUORESCENT PROTEIN; MICROSOMAL AMINOPEPTIDASE;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EX VIVO STUDY; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; LYMPHOID TISSUE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION; VIRUS REPLICATION; VIRUS STRAIN;

CYTOMEGALOVIRUS; DNA, VIRAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; LYMPHOCYTES; LYMPHOID TISSUE; ORGAN CULTURE TECHNIQUES; VIRUS REPLICATION;

EID: 41449088141     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0155     Document Type: Article

References (37)

1. Gillet JY, Bongain A, Monpoux F, and Mariani R: [Maternal-fetal transmission of HIV.] Arch Pediatr 1995;2:169-172.
2. King CA, Baillie J, and Sinclair JH: Human cytomegalovirus modulation of CCR5 expression on myeloid cells affects susceptibility to human immunodeficiency virus type 1 infection. J Gen Virol 2006;87:2171-2180.
3. Lurain NS, Robert ES, Xu J, et al.: HIV type 1 and cytomegalovirus coinfection in the female genital tract. J Infect Dis 2004;190:619-623.
4. Sheth PM, Danesh A, Sheung A, et al.: Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. J Infect Dis 2006;193:45-48.
5. Speck CE, Coombs RW, Koutsky LA, et al.: Risk factors for HIV-1 shedding in semen. Am J Epidemiol 1999;150:622-631.
6. Xu C, Politch JA, Mayer KH, and Anderson DJ: Human immunodeficiency virus type-1 episomal cDNA in semen. AIDS Res Ther 2005;2:9.
7. Grivel JC, Garcia M, Moss WJ, and Margolis LB: Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus. J Infect Dis 2005;192:71-78.
8. Grivel JC, Santoro F, Chen S, et al.: Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J Virol 2003; 77:8280-8289.
9. Lisco A, Grivel JC, Biancotto A, et al.: Viral interactions in human lymphoid tissue: HHV-7 suppresses the replication of CCR5-tropic HIV-1 via CD4 modulation. J Virol 2006;81(2):708-717.
10. Boivin G, Gilbert C, Gaudreau A, Greenfield I, Sudlow R, and Roberts NA: Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. J Infect Dis 2001;184:1598-1602.
11. Lurain NS, Kapell KS, Huang DD, et al.: Human cytomegalovirus UL144 open reading frame: Sequence hypervariability in low-passage clinical isolates. J Virol 1999;73:10040-10050.
12. Glushakova S, Baibakov B, Margolis LB, and Zimmerberg J: Infection of human tonsil histocultures: A model for HIV pathogenesis. Nat Med 1995;1:1320-1322.
13. Glushakova S, Baibakov B, Zimmerberg J, and Margolis LB: Experimental HIV infection of human lymphoid tissue: Correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res Hum Retroviruses 1997;13:461-471.
14. Essa S, Pacsa AS, Al-Attiyah R, El-Shazly A, Raghupathy R, and Said T: The use of flow cytometry for the detection of CMV-specific antigen (pp65) in leukocytes of kidney recipients. Clin Transplant 2000;14:147-151.
15. Siennicka J: Detection of CMV infected cells by flow cytometry - evaluation of MAbs CCH2 and AAC10 directed against early and late CMV antigens. Pol J Microbiol 2004;53:127-129.
16. Rabah R and Jaffe R: Early detection of cytomegalovirus in the allograft liver biopsy: A comparison of methods. Pediatr Pathol 1987;7:549-556.
17. Boeckh M and Nichols WG: The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004;103:2003-2008.
18. George SL, Wunschmann S, McCoy J, Xiang J, and Stapleton JT: Interactions between GB virus type C and HIV. Curr Infect Dis Rep 2002;4:550-558.
19. Moss WJ, Ryon JJ, Monze M, Cutts F, Quinn TC, and Griffin DE: Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis 2002;185:1035-1042.
20. Stapleton JT, Xiang J, and Williams CF: HIV and GB virus C coinfection. Lancet Infect Dis 2006;6:187-188; author reply, 188-189.
21. Watt G, Kantipong P, and Jongsakul K: Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 2003;36:1067-1069.
22. Grivel JC, Ito Y, Faga G, et al.: Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med 2001;7:1232-1235.
23. Kondo K, Xu J, and Mocarski ES: Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 1996; 93:11137-11142.
24. Hahn G, Jores R, and Mocarski ES: Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998;95:3937-3942.
25. Soderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, and Moller E: CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993;67:6576-6585.
26. Soderberg C, Larsson S, Bergstedt-Lindqvist S, and Moller E: Identification of blood mononuclear cells permissive of cytomegalovirus infection in vitro. Transplant Proc 1993;25:1416-1418.
27. Tocci MJ and St Jeor SC: Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus. Infect Immun 1979;23: 418-423.
28. Wang X, Huong SM, Chiu ML, Raab-Traub N, and Huang ES: Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 2003;424:456-461.
29. Riemann D, Gohring B, and Langner J: Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma. Immunol Lett 1994;42:19-23.
30. Riemann D, Schwachula A, Hentschel M, and Langner J: Demonstration of CD13/aminopeptidase N on synovial fluid T cells from patients with different forms of joint effusions. Immunobiology 1993;187:24-35.
31. Saho T, Kishida T, Hirano H, Hashikawa T, Shimabukuro Y, and Murakami S: Induction of CD13 on T-lymphocytes by adhesive interaction with gingival fibroblasts. J Dent Res 2003;82:893-898.
32. Jun Y, Kim E, Jin M, et al.: Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol 2000;164:805-811.
33. Larcher C, Recheis H, Sgonc R, Gottinger W, Huemer HP, and Irschick EU: Influence of viral infection on expression of cell surface antigens in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 1997;235:709-716.
34. Slobedman B, Mocarski ES, Arvin AM, Mellins ED, and Abendroth A: Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood 2002;100:2867-2873.
35. Malkevich N, Womack C, Pandya P, Grivel JC, Fauci AS, and Margolis L: Human immunodeficiency virus type 1 (HIV-1) non-B subtypes are similar to HIV-1 subtype B in that coreceptor specificity is a determinant of cytopathicity in human lymphoid tissue infected ex vivo. J Virol 2001;75:10520-10522.
36. Harari A, Vallelian F, Meylan PR, and Pantaleo G: Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005;174:1037-1045.
37. Biancotto A, Iglehart SJ, Vanpouille C, et al.: HIV-1 production and depletion of activated and non-activated cells in human lymphoid tissue ex vivo. Blood 2008;111:699-704.